AdamJasonSaltzmanMD
Cardiology • Fall River, MAAdult Congenital Heart Disease, Cardiac Electrophysiology, Heart Failure & Transplantation, Interventional Cardiology
Medical Director, Structural Heart Disease Program
Dr. Saltzman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
363 Highland Ave
Fall River, MA 02720Phone+1 508-973-7328Fax+1 508-973-7282
Education & Training
Massachusetts General HospitalFellowship, Interventional Cardiology, 2011 - 2012
New York Presbyterian Hospital(Cornell Campus)/Coney Island HospitalFellowship, Cardiovascular Disease, 2008 - 2011- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2004 - 2007
Tufts University School of MedicineClass of 2004
Certifications & Licensure
MA State Medical License 2011 - 2026
NY State Medical License 2005 - 2011- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Publications & Presentations
PubMed
- 36 citationsComparison of surgical pericardial drainage with percutaneous catheter drainage for pericardial effusion.Adam J. Saltzman, Yehuda Paz, A. Garvey Rene, Philip Green, Ahmed Hassanin
The Journal of Invasive Cardiology. 2012-11-01 - 51 citationsShort Communication: The Cardiac Myosin Binding Protein C Arg502Trp Mutation: A Common Cause of Hypertrophic CardiomyopathyAdam J. Saltzman, Debora Mancini-Dinardo, Chumei Li, Wendy K. Chung, Carolyn Y. Ho
Circulation Research. 2010-05-14 - 6 citationsEndothelial progenitor cells delivered into the pericardial space incorporate into areas of ischemic myocardiumAdam J. Saltzman, Sung W. Choi, Alexandra Dabreo, Wendy Baur, Eric R. Weiss
Cardiovascular Revascularization Medicine. 2010-10-01
Press Mentions
Abiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic ShockFebruary 13th, 2018
New Heart Procedure at Charlton Keeps 81-Year Old YoungDecember 4th, 2017
New Implant Blocks Blood ClotsNovember 29th, 2015
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
